PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
25-Jun-2025 Anesthesia Machines Market Set to Hit USD 18.6B by 2035 MARKITWIRED
25-Jun-2025 Dental Disinfectants Market Set for Steady Growth Through 2035 MARKITWIRED
25-Jun-2025 Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury Evotec SE
25-Jun-2025 U.S. biosimilar specialist Valorum Biologics LLC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® (aflibercept-mrbb) in the United States and Canada Formycon AG
25-Jun-2025 ThinkSono Secures Additional £4.5M / $6Mn Funding, Expands Team and Operations Across the UK, EU and U.S. ACCESS Newswire
25-Jun-2025 Nerve Repair and Regeneration Market to rise at 12% CAGR driven by motor function recovery tools by 2027 MediTech-Insights
25-Jun-2025 Companion Diagnostic Market set for ~13% CAGR growth amid expanding precision medicine use by 2027 MediTech-Insights
25-Jun-2025 Orthodontic Supplies Market to witness 7–9% CAGR growth with rising tooth decay and loss cases by 2027 MediTech-Insights
25-Jun-2025 Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury ACCESS Newswire
24-Jun-2025 Pulpfixin Partners With University of Dayton Research Institute to Validate Performance and Sustainability of Pulp-based Labware ACCESS Newswire
24-Jun-2025 CureVac Announces Voting Results of General Meeting CureVac
24-Jun-2025 Ivermectin Now Available Over-the-Counter in Arkansas - Iverpure ACCESS Newswire
24-Jun-2025 Strong demand for Formycon 2025/2029 Bond leads to early closing of subscription period Formycon AG
24-Jun-2025 Alpha Genesis Reinforces Commitment to "Make America Healthy Again" Initiative Through Research, Nutrition, and Public Engagement ACCESS Newswire
24-Jun-2025 CureVac Announces Voting Results of General Meeting ACCESS Newswire
24-Jun-2025 Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026 ACCESS Newswire
24-Jun-2025 New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine Lundbeck
24-Jun-2025 Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML Enterome
24-Jun-2025 Valneva Scotland Earns Prestigious Global Health and Safety Award Valneva
24-Jun-2025 Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025 Xlife Sciences AG